Roderic I. Pettigrew | |
---|---|
CEO of EnHealth and Executive Dean of EnMed, Texas A&M University | |
Assumed office November 2017 | |
Founding Director,NIBIB | |
In office 2002–2017 | |
Personal details | |
Born | Roderic I. Pettigrew Georgia,U.S. |
Education | Morehouse College RPI MIT University of Miami Leonard M. Miller School of Medicine|UMMSM |
Roderic Ivan Pettigrew is an American physicist,engineer,and physician who is CEO of EnHealth and Executive Dean for EnMed at Texas A&M University. From 2002-November 2017,he was the founding director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at the National Institutes of Health (NIH). [1] He is a pioneer and world expert in cardiovascular magnetic resonance imaging (MRI).
Pettigrew was born in Georgia,the second of three children. He spent his pre-college years [2] in Albany,Georgia in the 1960s,during the peak of the civil rights movement. His primary education was in a segregated school system,during the period that overlapped with passage and enactment of the Civil Rights Act of 1964.
Following 11th grade and without graduating from high school,Pettigrew accepted an early admission scholarship from Charles E. Merrill,Jr.,to attend Morehouse College in Atlanta,Georgia. While majoring in physics he also studied philosophy,art,and German at the Institute of European Studies for a year in Vienna,Austria,through a second Merrill scholarship. He received a Bachelor of Science degree in physics from Morehouse in 1972.
Pettigrew then attended Rensselaer Polytechnic Institute (RPI) which had begun a new program in medical physics,and in 1973 he received a Master of Science degree in nuclear science and engineering. He subsequently pursued a unique research program in applying nuclear engineering to medical problems at the Massachusetts Institute of Technology (MIT),which culminated in 1977 with a Ph.D. in applied radiation physics from the Department of Nuclear Engineering. There he was a Harvard-MIT Health Sciences and Technology Whitaker Fellow,where he helped research the application of boron-neutron capture therapy for malignant brain tumors. In 1979,Pettigrew received his M.D. from the Miller School of Medicine at the University of Miami in a then-novel program which only admitted students who already held a Ph.D. in a science field. This accelerated program over 24 consecutive months aimed to train physician-scientists who would bring new perspectives to meeting healthcare challenges.
Pettigrew completed a medical internship and residency in internal medicine at Emory University Affiliated Hospitals and in 1983 completed a residency in nuclear medicine at the University of California San Diego. There he began work on single-photon emission computed tomography and non-invasive cardiac imaging.
In 1983,Pettigrew undertook a position as clinical research scientist at Picker International,Inc.,where he began work in developing nuclear magnetic resonance imaging,later called MRI,specifically for the heart. Picker was the first company to manufacture an MRI scanner,and Pettigrew helped develop their technology for cardiovascular imaging. Of the first 10 Picker MRI scanners installed worldwide,Pettigrew co-developed,along with A.V. Lakshminarayanan,and installed the cardiac imaging software on all of these systems. These included the first units at the Mayo Clinic,Wake Forrest University,and the NIH Clinical Center and several systems in Europe.
In 1984,Pettigrew received a fellowship from the Robert Wood Johnson Foundation (RWJF) in their Harold Amos Medical Faculty Development Program,created to help achieve more appropriate representation and inclusion of minority scientists and scholars in academia. As an RWJF fellow,he moved to Emory University School of Medicine in the Department of Radiology and continued his work in developing non-invasive cardiovascular imaging employing nuclear medicine and MRI. At Emory,he partnered with scientists at Philips Medical Systems to develop the first industrial cardiovascular MRI software package (Philips Cardiac Package,1988). In 1989,when the Radiological Society of North America (RSNA) held its Diamond Jubilee 75th Anniversary meeting,then hailed as the largest medical meeting in the world,Pettigrew delivered the invited keynote,the Eugene Pendergrass New Horizons Lecture. This talk,titled Four Dimensional Cardiac MRI:Diagnostic Procedure of the Future,predicted the advanced medial technological approach being realized and built upon today.
In the 1990s,through appointments as professor in the Department of Cardiology at the Emory University School of Medicine,where he directed the Emory Center for Magnetic Resonance Research,and in the Department of Bioengineering at the Georgia Institute of Technology,his research continued to focus on applying MRI to the diagnosis of a variety of cardiac disorders,quantifying heart-wall function,imaging coronary arteries,and in quantifying blood flow across heart valves and in vessels,including congenital heart anomalies.
In 2002,Pettigrew was named the first director [3] of NIBIB,after contentious and prolonged effort by the national medical imaging [4] and bioengineering communities to establish an NIH institute that is dedicated to advancing health through these catalytic fields,known to be engines of scientific progress. [5] Of historical note is that Congress passed the bill to establish NIBIB (the National Institute of Biomedical Imaging and Bioengineering Establishment Act) just before Christmas recess in 2000,and President Bill Clinton signed it into law as the last legislative act of his presidency. [6]
Under Pettigrew's direction,NIBIB achieved rapid scientific growth and influence. The initial federal appropriation doubled and applications quadrupled from year 1 to year 2,bringing a new community of physical scientists and engineers into the NIH community. More than half of these applications were from investigators new to NIH. NIBIB partnered with the Howard Hughes Medical Institute led by Thomas Cech to train the next generation of medical researchers at the interface of the physical and life sciences and engineering.
Pettigrew also conceived the NIBIB Quantum Grants Program,designed to target major medical problems that would be transformative for health care and could be solved by technological innovation over a decade. In remarks [7] made in 2007,Pettigrew called the Quantum Program awards "Medical Moonshots," an analogy to President Kennedy's 1961 challenge to land a man on the moon before the end of the decade.
Pettigrew and NIBIB continued to lead technological innovation with a variety of creative national and international programs,including an effort to reduce the radiation dose patients receive in routine computed tomography (CT),building a national network to develop and deploy point-of-care diagnostic technologies,and establishing two joint programs with the government of India. NIBIB expanded its reach through the DEBUT Prize for undergraduate teams,the ESTEEMED program to increase STEM degrees among underrepresented undergraduate students,and the Trailblazer Award to promote early stage investigators who tackle high-reward challenges.
In 2014,NIBIB-sponsored research realized a major breakthrough in treating persons with complete paralysis due to spinal cord injury. This work continues and has subsequently been independently replicated at the Mayo Clinic. In 2017,researchers conducted a successful first-in-human study of a microneedle vaccine patch developed with support from an NIBIB Quantum Program grant. As well,NIBIB introduced a program in immunoengineering.
On behalf of NIH,Pettigrew currently also serves as the liaison to the U.S. Department of Energy and to the National Aeronautics and Space Administration (NASA),and is co-chairman of the Interagency Working Group on Medical Imaging,convened by the White House Office of Science &Technology Policy (OSTP). From 2013 to 2014 he served as acting chief officer for scientific workforce diversity at the NIH. He stepped down as NIBIB Director in November 2017 to assume the role of CEO of EnHealth and Executive Dean for EnMed at Texas A&M University in Houston.
Pettigrew was elected to the National Academy of Medicine (NAM) in 2007. He was elected to the National Academy of Engineering (NAE) in 2010 for "the use of MRI in human blood-flow studies and for leading advancements in bioengineering research and education as the initial director of NIBIB." [8] He was named as foreign fellow of the National Academy of Sciences India (NASI) in 2016. Pettigrew was selected as the 2020 recipient of the Vannevar Bush Award. [9]
Other distinctions include:
Magnetic resonance imaging (MRI) is a medical imaging technique used in radiology to form pictures of the anatomy and the physiological processes inside the body. MRI scanners use strong magnetic fields,magnetic field gradients,and radio waves to generate images of the organs in the body. MRI does not involve X-rays or the use of ionizing radiation,which distinguishes it from computed tomography (CT) and positron emission tomography (PET) scans. MRI is a medical application of nuclear magnetic resonance (NMR) which can also be used for imaging in other NMR applications,such as NMR spectroscopy.
Medical physics deals with the application of the concepts and methods of physics to the prevention,diagnosis and treatment of human diseases with a specific goal of improving human health and well-being. Since 2008,medical physics has been included as a health profession according to International Standard Classification of Occupation of the International Labour Organization.
Elias Zerhouni is an Algerian-born American scientist,radiologist and biomedical engineer.
The National Institute of Biomedical Imaging and Bioengineering (NIBIB),founded at the National Institutes of Health (NIH) in 2000,is located in Bethesda,Maryland. It is one of 27 institutes and centers that are part of NIH,an agency of the U.S. Department of Health and Human Services (HHS).
Bruce J. Tromberg is an American photochemist and a leading researcher in the field of biophotonics. He is the director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) within the National Institutes of Health (NIH). Before joining NIH,he was Professor of Biomedical Engineering at The Henry Samueli School of Engineering and of Surgery at the School of Medicine,University of California,Irvine. He was the principal investigator of the Laser Microbeam and Medical Program (LAMMP),and the Director of the Beckman Laser Institute and Medical Clinic at Irvine. He was a co-leader of the Onco-imaging and Biotechnology Program of the NCI Chao Family Comprehensive Cancer Center at Irvine.
Bin He is a Chinese American biomedical engineering scientist. He is the Trustee Professor of the Department of Biomedical Engineering,professor by courtesy in the Department of Electrical and Computer Engineering,and Professor of Neuroscience Institute,and was the head of the department of Biomedical Engineering at Carnegie Mellon University. Prior,he was Distinguished McKnight University Professor of Biomedical Engineering and Medtronic-Bakken Endowed Chair for Engineering in Medicine at the University of Minnesota. He previously served as the director of the Institute for Engineering in Medicine and the Center for Neuroengineering at the University of Minnesota. He was the Editor in Chief of the IEEE Transactions on Biomedical Engineering and serves as the editor in chief of IEEE Reviews in Biomedical Engineering. He was the president of the IEEE Engineering in Medicine &Biology Society (EMBS) from 2009 to 2010 and chair of International Academy of Medical and Biological Engineering from 2018 to 2021.
The Athinoula A. Martinos Center for Biomedical Imaging,usually referred to as just the "Martinos Center," is a major hub of biomedical imaging technology development and translational research. The Center is part of the Department of Radiology at Massachusetts General Hospital and is affiliated with both Harvard University and MIT. Bruce Rosen is the Director of the Center and Monica Langone is the Administrative Director.
Zang-Hee Cho is a Korean neuroscientist who developed the first Ring-PET scanner and the scintillation detector BGO. More recently,Cho developed the first PET-MRI fusion molecular imaging device for neuro-molecular imaging.
Nadine Barrie Smith (1962–2010) was an American biomedical researcher in the field of therapeutic ultrasound and non-invasive drug delivery. She was also an educator and mentor,especially to women students.
Vivian S. Lee is an American radiologist and health care/health technology executive. An Executive Fellow at Harvard Business School and senior lecturer at Harvard Medical School and Massachusetts General Hospital,Lee is the author of the book,The Long Fix:Solving America's Health Care Crisis with Strategies That Work for Everyone. Lee is also a senior fellow at the Institute for Healthcare Improvement (IHI) in Cambridge,Massachusetts. In 2019,she was named No. 11 in Modern Healthcare's 100 Most Influential People in Healthcare and is a frequent speaker at national and international meetings on the applications of big data,AI,and technology in healthcare,leadership and managing change,health equity,and on climate change and health system resilience.
Huntington Medical Research Institutes (HMRI) is an independent,nonprofit,applied medical research organization in Pasadena,California. The Institutes conduct laboratory and clinical work for the development of technology used in the diagnosis and treatment of disease. The Molecular Medicine programs,such as cancer genetics,molecular neurology,molecular pathology and tissue engineering,were conducted at the 99 North El Molino Avenue facility until April 2018. The Neural Engineering program is conducted at the 734 Fairmount Avenue building directly adjacent to Huntington Hospital. The Advanced Imaging Laboratory is located nearby at 10 Pico Street,as is the Liver Center at 660 South Fair Oaks Avenue. A new 35,000 square foot laboratory building for HMRI opened at 686 South Fair Oaks Avenue,Pasadena in April 2018. Programs in the new facility include neurolological and cardiovascular studies,as well as preeclampsia research.
Bruce Rosen is an American physicist and radiologist and a leading expert in the area of functional neuroimaging. His research for the past 30 years has focused on the development and application of physiological and functional nuclear magnetic resonance techniques,as well as new approaches to combine functional magnetic resonance imaging (fMRI) data with information from other modalities such as positron emission tomography (PET),magnetoencephalography (MEG) and noninvasive optical imaging. The techniques his group has developed to measure physiological and metabolic changes associated with brain activation and cerebrovascular insult are used by research centers and hospitals throughout the world.
Ferenc Andras Jolesz was a Hungarian-American physician and scientist best known for his research on image guided therapy,the process by which information derived from diagnostic imaging is used to improve the localization and targeting of diseased tissue to monitor and control treatment during surgical and interventional procedures. He pioneered the field of Magnetic Resonance Imaging-guided interventions and introduced of a variety of new medical procedures based on novel combinations of imaging and therapy delivery.
James S. Hyde was an American biophysicist. He held the James S. Hyde chair in Biophysics at the Medical College of Wisconsin (MCW) where he specialized in magnetic resonance instrumentation and methodology development in two distinct areas:electron paramagnetic resonance (EPR) spectroscopy and magnetic resonance imaging (MRI). He is senior author of the widely cited 1995 paper by B.B. Biswal et al. reporting the discovery of resting state functional connectivity (fcMRI) in the human brain. He also served as Director of the National Biomedical EPR Center,a Research Resource supported by the National Institutes of Health. He was author of more than 400 peer-reviewed papers and review articles and held 35 U.S. Patents. He was recognized by Festschrifts in both EPR and fcMRI.
Ron Kikinis is an American physician and scientist best known for his research in the fields of imaging informatics,image guided surgery,and medical image computing. He is a professor of radiology at Harvard Medical School. Kikinis is the founding director of the Surgical Planning Laboratory in the Department of Radiology at Brigham and Women's Hospital,in Boston,Massachusetts. He is the vice-chair for Biomedical Informatics Research in the Department of Radiology.
Elliot R. McVeigh is a professor of bioengineering,Medicine and Radiology at the University of California,San Diego (UCSD). His research utilises low dose CT imaging and MR imaging techniques to identify those people at substantially higher risk for heart attacks.
Jonathan S. Lewin is an American neuroradiologist specializing in medical imaging research with an emphasis on the investigation,development,and translation of new magnetic resonance imaging (MRI) techniques. He is the former executive vice president for health affairs (EVPHA) and executive director of the Woodruff Health Sciences Center for Emory University,and former President,CEO,and chairman of the board of Emory Healthcare. He currently serves as professor of radiology,biomedical engineering,and neurosurgery in the Emory School of Medicine and as professor of health policy and management in the Rollins School of Public Health.
Daniel Kevin Sodickson is an American physicist and an expert in the field of biomedical imaging. A past president and gold medalist of the International Society for Magnetic Resonance in Medicine,he is credited with foundational work in parallel magnetic resonance imaging (MRI),in which distributed arrays of detectors are used to gather magnetic resonance images at previously inaccessible speeds. Sodickson is an elected Fellow of the US National Academy of Inventors. He currently serves as Vice-Chair for Research in the Department of Radiology at New York University (NYU) Grossman School of Medicine,as Director of the department's Bernard and Irene Schwartz Center for Biomedical Imaging,as Principal Investigator of the Center for Advanced Imaging Innovation and Research,and as Co-Director of NYU's Tech4Health Institute.
Sanjay Rajagopalan is the Herman Hellerstein Professor of Medicine and Chief Scientific and Medical Officer at the Harrington Heart and Vascular Institute,University Hospitals and Professor Medicine at Case Western Reserve University (CWRU) in Cleveland,Ohio. He holds secondary appointments in the Case Western Reserve University Departments of Physiology,Radiology and Biomedical Engineering. Much of his research has been on using technology to guide the detection and treatment of heart disease and more recently on the impact of environmental exposures and climate change on cardiovascular health.
Amir Amini is the Professor and Endowed Chair in Bioimaging at the University of Louisville. Prior to this,he was the founder of the Cardiovascular Image Analysis Laboratory and associate professor at the Washington University in St. Louis. He was elected a fellow of the IEEE in 2007,the College of Fellows of the American Institute of Medical and Biological Engineering in 2017,the International Society for Optics,Photonics,and Imaging in 2019,and the Asia-Pacific Artificial Intelligence Association in 2021.
This article needs additional or more specific categories .(April 2021) |